EnWave Corporation (ENW) - Total Liabilities
Based on the latest financial reports, EnWave Corporation (ENW) has total liabilities worth CA$6.55 Million CAD (≈ $4.74 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore ENW cash flow conversion to assess how effectively this company generates cash.
EnWave Corporation - Total Liabilities Trend (2014–2025)
This chart illustrates how EnWave Corporation's total liabilities have evolved over time, based on quarterly financial data. See EnWave Corporation (ENW) net assets for net asset value and shareholders' equity analysis.
EnWave Corporation Competitors by Total Liabilities
The table below lists competitors of EnWave Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Sunrise New Energy Co. Ltd
NASDAQ:EPOW
|
USA | $150.12 Million |
|
Andalan Perkasa Abadi Tbk PT
JK:NASA
|
Indonesia | Rp27.32 Billion |
|
Excel Force MSC Bhd
KLSE:0065
|
Malaysia | RM16.39 Million |
|
Superlon Holdings Bhd
KLSE:7235
|
Malaysia | RM46.92 Million |
|
Jupiter Energy Ltd
AU:JPR
|
Australia | AU$25.00 Million |
|
IQuest Co. Ltd.
KQ:262840
|
Korea | ₩47.86 Billion |
|
Viking Kagit ve Seluloz AS
IS:VKING
|
Turkey | TL3.73 Billion |
Liability Composition Analysis (2014–2025)
This chart breaks down EnWave Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see EnWave Corporation market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.26 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.55 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.35 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how EnWave Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for EnWave Corporation (2014–2025)
The table below shows the annual total liabilities of EnWave Corporation from 2014 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-09-30 | CA$6.55 Million ≈ $4.74 Million |
+75.93% |
| 2024-09-30 | CA$3.73 Million ≈ $2.70 Million |
-16.63% |
| 2023-09-30 | CA$4.47 Million ≈ $3.23 Million |
-45.63% |
| 2022-09-30 | CA$8.22 Million ≈ $5.95 Million |
+7.40% |
| 2021-09-30 | CA$7.65 Million ≈ $5.54 Million |
-37.84% |
| 2020-09-30 | CA$12.31 Million ≈ $8.91 Million |
+0.05% |
| 2019-09-30 | CA$12.31 Million ≈ $8.90 Million |
+134.85% |
| 2018-09-30 | CA$5.24 Million ≈ $3.79 Million |
+58.21% |
| 2017-09-30 | CA$3.31 Million ≈ $2.40 Million |
+20.31% |
| 2016-09-30 | CA$2.75 Million ≈ $1.99 Million |
-24.12% |
| 2015-09-30 | CA$3.63 Million ≈ $2.62 Million |
-33.99% |
| 2014-09-30 | CA$5.50 Million ≈ $3.98 Million |
-- |
About EnWave Corporation
EnWave Corporation designs, constructs, markets, and sells vacuum-microwave dehydration machinery for the food, cannabis, and biomaterial industries in Canada, the United States, and internationally. The company licenses radiant energy vacuum (REV) technology that applies microwave energy under vacuum for drying food products, cannabis, biomaterials, and pharmaceutical products and ingredients. I… Read more